Clover Health Investments Sees Unusually High Options Volume (NASDAQ:CLOV)

Clover Health Investments, Corp. (NASDAQ:CLOVGet Free Report) saw unusually large options trading activity on Friday. Traders acquired 26,744 call options on the company. This is an increase of approximately 222% compared to the average volume of 8,293 call options.

Hedge Funds Weigh In On Clover Health Investments

A number of hedge funds have recently made changes to their positions in the business. Jupiter Asset Management Ltd. raised its stake in shares of Clover Health Investments by 18.1% in the 1st quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company’s stock valued at $3,593,000 after acquiring an additional 692,878 shares during the period. Connor Clark & Lunn Investment Management Ltd. grew its holdings in Clover Health Investments by 2.6% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 813,695 shares of the company’s stock valued at $879,000 after purchasing an additional 20,813 shares in the last quarter. Swiss National Bank grew its holdings in Clover Health Investments by 1.6% during the 3rd quarter. Swiss National Bank now owns 782,200 shares of the company’s stock valued at $845,000 after purchasing an additional 12,400 shares in the last quarter. Citigroup Inc. grew its holdings in Clover Health Investments by 4,040.8% during the 3rd quarter. Citigroup Inc. now owns 372,421 shares of the company’s stock valued at $402,000 after purchasing an additional 363,427 shares in the last quarter. Finally, Bayesian Capital Management LP acquired a new stake in Clover Health Investments during the 1st quarter valued at $142,000. Hedge funds and other institutional investors own 19.77% of the company’s stock.

Clover Health Investments Trading Up 21.4 %

Shares of CLOV stock opened at $1.25 on Friday. The company’s fifty day simple moving average is $0.90 and its 200-day simple moving average is $0.90. Clover Health Investments has a 52 week low of $0.61 and a 52 week high of $1.63. The company has a market cap of $620.55 million, a PE ratio of -3.68 and a beta of 2.09.

Clover Health Investments (NASDAQ:CLOVGet Free Report) last issued its earnings results on Tuesday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.02. Clover Health Investments had a negative net margin of 8.63% and a negative return on equity of 48.07%. The business had revenue of $346.92 million for the quarter, compared to the consensus estimate of $316.10 million. Equities research analysts expect that Clover Health Investments will post -0.21 EPS for the current fiscal year.

Clover Health Investments Company Profile

(Get Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

See Also

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.